On April 19, 2023, we welcomed Singularity University Colombia in our offices in the context of their visit to Argentina’s biotech ecosystem. We also welcomed Oncoliq, Limay Biosciences, and Bitgenia. We all had the opportunity to present our proposal and highlight our impact.
Singularity University focuses on training visionary leaders to harness technology and improve the lives of millions of people for years to come. Stämm had its own start in their Global Innovation Program and has embraced its visionary approach to change the world. Singularity University Colombia carries out this type of visits to promote curiosity in organizations, teams, and people who pursue this purpose at a regional level.
During the event, the startups showed their potential of innovation and the complementarity of our proposals, since we all pursue the goal of positively impacting people’s lives.
Oncoliq is revolutionizing cancer diagnosis by using liquid biopsies to democratize access to early detection. Limay Biosciences is developing innovative biotechnologies to decentralize and democratize access to molecular tests in health and food quality. Bitgenia is developing genetic tests that allow people to own their genomic information and share it with professionals to improve their quality of life.
At Stämm, we are working to democratize bioproduct access by decentralizing and digitizing the biomanufacturing industry. We have developed the first methodology for continuous industrial production of biologics and cell therapies. It was a pleasure to show attendees our laboratories and offices, where we carry out our research and development.
We consider this type of event very valuable to make visible the great impact that innovative biotechnological proposals will have in LATAM and in the world